| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8276450 | Journal of the Neurological Sciences | 2015 | 7 Pages |
Abstract
These preliminary results suggest that selegiline administered in the subacute phase can promote cognitive functioning in stroke patients. Further studies will elucidate whether and how this enhancement can impact on functional recovery in the short and in the long term.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Michelangelo Bartolo, Chiara Zucchella, Annarita Capone, Giorgio Sandrini, Francesco Pierelli,